Rheumatology Network's Top 5: December 10, 2023

Published on: 

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending December 10, 2022.

Juvenile Fibromyalgia Intervention Program Effectively Manages Patients Remotely, In-Person

Enrollment in the FIT Teens program, which began in January 2018, was paused in March 2020 to revise operations manuals, conduct remote treatment sessions to evaluate accuracy and fidelity, obtain regulatory approvals, and train staff on the new procedures.

Self-Advocacy Platform Allows Patients with Autoimmune Diseases to Discover Triggers, Improve Disease Management

Mymee, a self-advocacy platform, utilizes technological innovation, such as self-tracking, data analytics, and expert health coaching, to improve access and offer hope to these patients by uncovering their unique triggers, managing disease flares, and improving quality of life.

Patient Perspective: Support Program Helps Patients with Lupus Manage Their Disease, Improve QoL

"Discovering your unique triggers can feel frustrating but with the right tools and support, it is possible to find answers," Hinton-Green emphasized. "You don’t have to do it alone."

Addition of TNFi, Triple Therapy Improved Vascular Inflammation in Patients with RA

Although previous studies have indicated differential effects on cardiovascular risk between immunomodulators, results showed similar reductions across both treatment groups.

Glucocorticoid Treatment, Chronic Lung Disease Associated with Increased Risk of Respiratory Tract Infection in PsA, SpA

“Respiratory tract infections constitute the most common infections in patients with rheumatic diseases, especially under immunosuppressive treatment,” investigators explained.